A Comprehensive Appraisal of Risk Prediction Models for Cardiogenic Shock.

ABSTRACT Despite advances in early revascularization, percutaneous hemodynamic support platforms, and systems of care, cardiogenic shock (CS) remains associated with a mortality rate higher than 50%. Several risk stratification models have been derived since the 1990 s to identify patients at high risk of adverse outcomes. Still, limited information is available on the differences between scoring systems and their relative applicability to both acute myocardial infarction and advanced decompensated heart failure CS. Thus, we reviewed the similarities, differences, and limitations of published CS risk prediction models and herein discuss their suitability to the contemporary management of CS care.

[1]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[2]  F. Pappalardo,et al.  Validation of Prognostic Scores in Extracorporeal Life Support: A Multi-Centric Retrospective Study , 2021, Membranes.

[3]  M. Bell,et al.  Defining Shock and Preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit Patients. , 2021, Circulation. Heart failure.

[4]  V. Rao,et al.  Predicting Survival After VA-ECMO for Refractory Cardiogenic Shock: Validating the SAVE Score , 2020, CJC open.

[5]  D. Burkhoff,et al.  Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality. , 2020, JACC. Heart failure.

[6]  M. Bell,et al.  Shock in the cardiac intensive care unit: Changes in epidemiology and prognosis over time. , 2020, American heart journal.

[7]  B. Gersh,et al.  Sex Disparities in the Management and Outcomes of Cardiogenic Shock Complicating Acute Myocardial Infarction in the Young , 2020, Circulation. Heart failure.

[8]  B. Gersh,et al.  Sex and Gender Disparities in the Management and Outcomes of Acute Myocardial Infarction-Cardiogenic Shock in Older Adults. , 2020, Mayo Clinic proceedings.

[9]  N. Desai,et al.  Transition to Advanced Therapies Among Elderly Patients Supported by Extracorporeal Membrane Oxygenation Therapy: Chouairi et al, ECMO in the Elderly. , 2020, Journal of cardiac failure.

[10]  N. Shah,et al.  Cardiogenic shock and cardiac arrest complicating ST-segment elevation myocardial infarction in the United States, 2000-2017. , 2020, Resuscitation.

[11]  N. Shah,et al.  Long-Term Outcomes of Acute Myocardial Infarction With Concomitant Cardiogenic Shock and Cardiac Arrest. , 2020, The American journal of cardiology.

[12]  Wei-Ren Lan,et al.  Application and Comparison of Different Prognostic Scoring Systems in Patients Who Underwent Cardiologist-Managed Percutaneous Cardiopulmonary Support. , 2020, Acta Cardiologica Sinica.

[13]  B. Gersh,et al.  Epidemiological Trends in the Timing of In-Hospital Death in Acute Myocardial Infarction-Cardiogenic Shock in the United States , 2020, Journal of clinical medicine.

[14]  D. Burkhoff,et al.  Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support. , 2020, Circulation.

[15]  P. Noseworthy,et al.  Burden of Arrhythmias in Acute Myocardial Infarction Complicated by Cardiogenic Shock. , 2020, The American journal of cardiology.

[16]  A. Jaffe,et al.  Complications in Patients with Acute Myocardial Infarction Supported with Extracorporeal Membrane Oxygenation , 2020, Journal of clinical medicine.

[17]  B. Gersh,et al.  Regional Variation in the Management and Outcomes of Acute Myocardial Infarction With Cardiogenic Shock in the United States , 2020, Circulation. Heart failure.

[18]  H. Thiele,et al.  External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients. , 2020, European heart journal. Acute cardiovascular care.

[19]  G. Lemesle,et al.  Etiology and Prognosis of Cardiogenic Shock in a Secondary Center without Surgical Back-Up , 2019, Cardiology research and practice.

[20]  B. Gersh,et al.  Extracorporeal Membrane Oxygenation Use in Acute Myocardial Infarction in the United States, 2000 to 2014. , 2019, Circulation. Heart failure.

[21]  B. Gersh,et al.  Acute respiratory failure and mechanical ventilation in cardiogenic shock complicating acute myocardial infarction in the USA, 2000–2014 , 2019, Annals of Intensive Care.

[22]  E. Ohman,et al.  Management of cardiogenic shock complicating myocardial infarction: an update 2019. , 2019, European heart journal.

[23]  D. Holmes,et al.  Hospital-Level Disparities in the Outcomes of Acute Myocardial Infarction With Cardiogenic Shock. , 2019, The American journal of cardiology.

[24]  Dennis H. Murphree,et al.  Utilization of Palliative Care for Cardiogenic Shock Complicating Acute Myocardial Infarction: A 15‐Year National Perspective on Trends, Disparities, Predictors, and Outcomes , 2019, Journal of the American Heart Association.

[25]  B. Gersh,et al.  Sex disparities in acute kidney injury complicating acute myocardial infarction with cardiogenic shock , 2019, ESC heart failure.

[26]  J. Ornato,et al.  SCAI clinical expert consensus statement on the classification of cardiogenic shock , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[27]  Dennis H. Murphree,et al.  Cardiogenic Shock in Takotsubo Cardiomyopathy Versus Acute Myocardial Infarction: An 8-Year National Perspective on Clinical Characteristics, Management, and Outcomes. , 2019, JACC. Heart failure.

[28]  L. Stevenson,et al.  Trends in Utilization and Outcomes of Pulmonary Artery Catheterization in Heart Failure With and Without Cardiogenic Shock. , 2019, Journal of cardiac failure.

[29]  C. O'connor,et al.  Standardized Team-Based Care for Cardiogenic Shock. , 2019, Journal of the American College of Cardiology.

[30]  D. Morrow,et al.  Epidemiology of Shock in Contemporary Cardiac Intensive Care Units: Data From the Critical Care Cardiology Trials Network Registry , 2019, Circulation. Cardiovascular quality and outcomes.

[31]  R. Yeh,et al.  Extracorporeal Membrane Oxygenation Use in Cardiogenic Shock: Impact of Age on In-Hospital Mortality, Length of Stay, and Costs , 2019, Critical care medicine.

[32]  Dennis H. Murphree,et al.  Development and performance of a novel vasopressor-driven mortality prediction model in septic shock , 2018, Annals of Intensive Care.

[33]  Biao Xu,et al.  The value of shock index in prediction of cardiogenic shock developed during primary percutaneous coronary intervention , 2018, BMC Cardiovascular Disorders.

[34]  C. Berry,et al.  Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS. , 2018, Journal of the American College of Cardiology.

[35]  A. Mebazaa,et al.  Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. , 2018, Journal of the American College of Cardiology.

[36]  D. Boulmier,et al.  Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score , 2018, European heart journal.

[37]  C. Hassager,et al.  Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients , 2018, European heart journal. Acute cardiovascular care.

[38]  K. Alaswad,et al.  Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[39]  H. Thiele,et al.  PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock , 2017, The New England journal of medicine.

[40]  E. Ohman,et al.  Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association , 2017, Circulation.

[41]  K. Anstrom,et al.  Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial. , 2017, Journal of the American College of Cardiology.

[42]  H. Thiele,et al.  Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[43]  E. Ohman,et al.  Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. , 2017, The American journal of cardiology.

[44]  S. Shin,et al.  Validation of the Shock Index, Modified Shock Index, and Age Shock Index for Predicting Mortality of Geriatric Trauma Patients in Emergency Departments , 2016, Journal of Korean medical science.

[45]  S. Champion Toward Catecholamine Responsiveness in Cardiogenic Shock: Insights from the CRASH Score , 2016, The International journal of artificial organs.

[46]  G. Schuler,et al.  Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial. , 2016, American heart journal.

[47]  P. Leprince,et al.  The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock , 2016, Intensive Care Medicine.

[48]  S. Chaparro,et al.  Incidence of Hemolysis in Patients with Cardiogenic Shock Treated with Impella Percutaneous Left Ventricular Assist Device , 2014, ASAIO journal.

[49]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[50]  Michael Bailey,et al.  Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. , 2015, European heart journal.

[51]  E. Ohman,et al.  Management of cardiogenic shock. , 2015, European heart journal.

[52]  Holger Thiele,et al.  Clinical picture and risk prediction of short‐term mortality in cardiogenic shock , 2015, European journal of heart failure.

[53]  D. Yellon,et al.  Myocardial reperfusion injury: looking beyond primary PCI. , 2013, European heart journal.

[54]  James O. Mudd,et al.  The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[55]  Huadong Zhu,et al.  Modified shock index and mortality rate of emergency patients. , 2012, World journal of emergency medicine.

[56]  Jorge Yarzebski,et al.  Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. , 2010, The American journal of medicine.

[57]  H. White,et al.  A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. , 2010, American heart journal.

[58]  J. Vincent,et al.  Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.

[59]  M. Mack,et al.  Assessment of the SYNTAX score in the Syntax study. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[60]  G. De Luca,et al.  Cardiogenic shock developing in the coronary care unit in patients with ST-elevation myocardial infarction , 2008, Journal of cardiovascular medicine.

[61]  Therapy Study Investigators,et al.  A comparison of epinephrine and norepinephrine in critically ill patients , 2008, Intensive Care Medicine.

[62]  M. Hamon,et al.  Prognostic impact of right ventricular involvement in patients with acute myocardial infarction: Meta-analysis , 2008, Critical care medicine.

[63]  T. Fabian,et al.  New vitals after injury: shock index for the young and age x shock index for the old. , 2008, The Journal of surgical research.

[64]  D. Yellon,et al.  Myocardial reperfusion injury. , 2007, The New England journal of medicine.

[65]  Min Zhang,et al.  A risk‐predictive score for cardiogenic shock after acute myocardial infarction in Chinese patients , 2007, Clinical cardiology.

[66]  N. Chi,et al.  Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue* , 2006, Critical care medicine.

[67]  L. Klein,et al.  Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. , 2005, The American journal of cardiology.

[68]  T. LeJemtel,et al.  Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. , 2004, Journal of the American College of Cardiology.

[69]  H. White,et al.  Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. , 2003, Journal of the American College of Cardiology.

[70]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[71]  R. Califf,et al.  Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. , 1999, American heart journal.

[72]  J. Gurwitz,et al.  Temporal trends in cardiogenic shock complicating acute myocardial infarction. , 1999, The New England journal of medicine.

[73]  E R Bates,et al.  Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, Journal of the American College of Cardiology.

[74]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[75]  M. Gheorghiade,et al.  Risk identification at the time of admission to coronary care unit in patients with suspected myocardial infarction. , 1988, American heart journal.